What's breaking now, across thousands of outlets.
Rather than deplete malfunctioning B cells as many other emerging autoimmune drugs do, Ai3Bio’s therapies are designed to eliminate a particular group of T helper cells.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
The equity investment comes alongside a deal to test Summit’s ivonescimab alongside potentially many AstraZeneca drugs — but doesn’t hand the pharmaceutical company any ownership rights.
South Africa’s latest mortality figures put cardiovascular disease firmly in focus, with hypertension and cerebrovascular diseases among the country’s leading causes of death.
Recent PPB alerts have involved falsified cancer medicines such as Herceptin, Avastin, Ibrance,...
Deadly synthetic opioids disguised as legitimate painkillers are being sold online across Europe, as counterfeit medicines linked to multiple deaths in the Netherlands expose the dark side of…
Drugmakers and investors have ramped up their spending and R&D attention on autoimmune diseases in recent years, with a proliferation of bispecific T cell engagers, various approaches to CAR-T cell…
During Donald Trump’s first presidency, American public opinion broadly shifted leftward. But a new study reveals this "liberal rebound" was accompanied by surging emotional hostility between…
